Skip to search formSkip to main contentSkip to account menu

ferucarbotran

Known as: carboxydextran-coated superparamagnetic iron oxide 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Organic Chemicalsferumoxides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT.
OBJECTIVES Our aim was to determine whether ablated liver parenchyma surrounding a tumour can be assessed by MRI with… 
Highly Cited
2009
Highly Cited
2009
The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells.
For in vivo applications of magnetically labeled stem cells, biological effects of the labeling procedure have to be precluded… 
Highly Cited
2009
Highly Cited
2009
Relaxation effects of ferucarbotran‐labeled mesenchymal stem cells at 1.5T and 3T: Discrimination of viable from lysed cells
Human mesenchymal stem cells (hMSCs) were labeled with Ferucarbotran by simple incubation and cultured for up to 14 d. Iron… 
2009
2009
Differentiation of well‐differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: Value of SPIO‐enhanced MR imaging at 3.0 Tesla
To determine the diagnostic value of superparamagnetic iron oxide (SPIO)‐enhanced MRI for the differentiation of well… 
2008
2008
Selective induction hyperthermia following transcatheter arterial embolization with a mixture of nano-sized magnetic particles (ferucarbotran) and embolic materials: feasibility study in rabbits
PurposeTo evaluate the possibility of selective hyperthermia following transcatheter arterial embolization (TAE) with… 
Highly Cited
2007
Highly Cited
2007
Superparamagnetic iron oxide (SPIO)‐enhanced liver MRI with ferucarbotran: Efficacy for characterization of focal liver lesions
To evaluate the efficacy of ferucarbotran in T2‐weighted (T2W) fast spin‐echo (FSE) and T2*W gradient‐echo (GRE) sequences for… 
2006
2006
Comparison of Gadolinium-BOPTA and Ferucarbotran-Enhanced Three-Dimensional T1-Weighted Dynamic Liver Magnetic Resonance Imaging in the Same Patient
Objectives:We sought to compare signal changes using Ferucarbotran and gadobenate dimeglumine (Gd-BOPTA) in dynamic 3D T1… 
2006
2006
Detection of hepatic metastases using ferucarbotran‐enhanced MR imaging: Feasibility and diagnostic accuracy of three‐dimensional sensitivity‐encoding water‐excitation multishot echo‐planar sequence…
To evaluate the diagnostic accuracy of a ferucarbotran‐enhanced three‐dimensional sensitivity‐encoding water‐excitation multishot… 
2006
2006
Local Arterial Infusion of Superparamagnetic Iron Oxide Particles in Hepatocellular Carcinoma: A Feasibility and 3.0 T MRI Study
Objectives:We sought to prove feasibility of selective arterial infusion of superparamagnetic iron oxide (SPIO) particles in… 
2005
2005
Clinical Management of Hepatic Malignancies: Ferucarbotran-Enhanced Magnetic Resonance Imaging Versus Contrast-Enhanced Spiral Computed Tomography
This study compares ferucarbotran-enhanced magnetic resonance (MR) imaging with spiral computed tomography (CT) in the clinical… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)